BioAtla, Inc. (BCAB) vs Cullinan Therapeutics, Inc. (CGEM)
Detailed comparison between BioAtla, Inc., Cullinan Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)Cullinan Therapeutics, Inc. (CGEM)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
Cullinan Therapeutics, Inc.
CGEM
| Metric | BioAtla, Inc. (BCAB) | Cullinan Therapeutics, Inc. (CGEM) |
|---|---|---|
| Current Price | $0.69 | $5.93 |
| Change | -0.00 (-0.52%) | -0.04 (-0.67%) |
| Market Cap | $0.04B | $0.35B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.47 | -1.82 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $2.52 | $17.98 |
| 52-Week Low | $0.24 | $5.86 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.14 | $-3.17 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | 53.55% | 46.36% | -60.24% | -97.78% | -97.78% | -97.78% |
| CGEM | -20.83% | -43.84% | -64.62% | -80.17% | -80.17% | -80.17% |